NO20021379L - Benzodiazepin-derivater, fremstilling og anvendelse derav - Google Patents

Benzodiazepin-derivater, fremstilling og anvendelse derav

Info

Publication number: NO20021379L
Authority: NO; Norway
Prior art keywords: preparation; benzodiazepine derivatives; prodrugs; compounds; values
Prior art date: 1999-09-28

Application number

NO20021379A

Other languages

English (en)

Norwegian (no)

Other versions

NO20021379D0 (no

Inventor

Wilfried Lubisch

Michael Kock

Thomas Hoeger

Roland Grandel

Reinhold Mueller

Sabine Schult

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-28

Filing date

2002-03-20

Publication date

2002-03-20

2002-03-20 Application filed by Basf Ag filed Critical Basf Ag

2002-03-20 Publication of NO20021379D0 publication Critical patent/NO20021379D0/no

2002-03-20 Publication of NO20021379L publication Critical patent/NO20021379L/no

Links

229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Surgery (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pulmonology (AREA)

NO20021379A 1999-09-28 2002-03-20 Benzodiazepin-derivater, fremstilling og anvendelse derav NO20021379L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19946289A DE19946289A1 (de)	1999-09-28	1999-09-28	Benzodiazepin-Derivate, deren Herstellung und Anwendung
PCT/EP2000/009023 WO2001023386A2 (de)	1999-09-28	2000-09-15	Benzodiazepin-derivate, deren herstellung und anwendung

Publications (2)

Publication Number	Publication Date
NO20021379D0 NO20021379D0 (no)	2002-03-20
NO20021379L true NO20021379L (no)	2002-03-20

Family

ID=7923476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021379A NO20021379L (no)	1999-09-28	2002-03-20	Benzodiazepin-derivater, fremstilling og anvendelse derav

Country Status (21)

Country	Link
EP (1)	EP1222191B1 (ko)
JP (1)	JP2003510324A (ko)
KR (1)	KR20020031602A (ko)
CN (1)	CN1376156A (ko)
AR (1)	AR025721A1 (ko)
AT (1)	ATE310003T1 (ko)
AU (1)	AU7656700A (ko)
BG (1)	BG106444A (ko)
BR (1)	BR0014326A (ko)
CA (1)	CA2384265A1 (ko)
DE (2)	DE19946289A1 (ko)
ES (1)	ES2251405T3 (ko)
HK (1)	HK1048994A1 (ko)
HU (1)	HUP0203225A3 (ko)
IL (1)	IL148419A0 (ko)
NO (1)	NO20021379L (ko)
PL (1)	PL354118A1 (ko)
SK (1)	SK3802002A3 (ko)
TR (1)	TR200200820T2 (ko)
WO (1)	WO2001023386A2 (ko)
ZA (2)	ZA200104196B (ko)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20010573B1 (en)	1999-01-11	2006-04-30	Agouron Pharmaceuticals	Tricyclic inhibitors of poly(adp-ribose) polymerases
WO2003103666A2 (en) *	2002-06-07	2003-12-18	Altana Pharma Ag	Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
ATE405658T1 (de)	2002-07-26	2008-09-15	Basf Plant Science Gmbh	Neue selektionsverfahren
WO2005028467A1 (en)	2003-09-15	2005-03-31	Anadys Pharmaceuticals, Inc.	Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7772271B2 (en)	2004-07-14	2010-08-10	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7868037B2 (en)	2004-07-14	2011-01-11	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
NZ553329A (en)	2004-07-22	2010-09-30	Ptc Therapeutics Inc	Thienopyridines for treating hepatitis C
EP2166099B1 (en)	2005-03-08	2012-12-19	BASF Plant Science GmbH	Expression enhancing intron sequences
US7662824B2 (en)	2005-03-18	2010-02-16	Janssen Pharmaceutica Nv	Acylhydrazones as kinase modulators
JP2013511979A (ja)	2009-11-27	2013-04-11	ビーエーエスエフプラントサイエンスカンパニーゲーエムベーハー	キメラエンドヌクレアーゼおよびその使用
WO2011064750A1 (en)	2009-11-27	2011-06-03	Basf Plant Science Company Gmbh	Chimeric endonucleases and uses thereof
AU2010325549B2 (en)	2009-11-27	2017-04-20	Basf Plant Science Company Gmbh	Optimized endonucleases and uses thereof
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
US9611267B2 (en)	2012-06-13	2017-04-04	Incyte Holdings Corporation	Substituted tricyclic compounds as FGFR inhibitors
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
WO2014037313A1 (de) *	2012-09-05	2014-03-13	Bayer Cropscience Ag	Verwendung substituierter benzodiazepinone und benzazepinone oder deren salze als wirkstoffe gegen abiotischen pflanzenstress
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
TWI649318B (zh)	2013-04-19	2019-02-01	英塞特控股公司	作為ｆｇｆｒ抑制劑之雙環雜環
WO2015174511A1 (ja)	2014-05-16	2015-11-19	塩野義製薬株式会社	Ｈｉｖ複製阻害作用を有する３環性複素環誘導体
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
AU2016219822B2 (en)	2015-02-20	2020-07-09	Incyte Holdings Corporation	Bicyclic heterocycles as FGFR inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
SG11201709634QA (en) *	2015-05-29	2017-12-28	Shionogi & Co	Nitrogen-containing tricyclic derivative having hiv replication inhibitory activity
CN105153195B (zh) *	2015-09-01	2017-09-26	汤文建	一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
ES2991427T3 (es)	2018-05-04	2024-12-03	Incyte Corp	Formas sólidas de un inhibidor de FGFR y procedimientos para preparar las mismas
TW201946630A (zh)	2018-05-04	2019-12-16	美商英塞特公司	Fgfr抑制劑之鹽
EP3886854A4 (en)	2018-11-30	2022-07-06	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
US11628162B2 (en)	2019-03-08	2023-04-18	Incyte Corporation	Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en)	2019-07-09	2021-01-14	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
GEAP202415945A (en)	2019-10-14	2024-04-25	Incyte Corp	Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CA3163875A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
AU2020395185A1 (en)	2019-12-04	2022-06-02	Incyte Corporation	Derivatives of an FGFR inhibitor
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
EP4323405A1 (en)	2021-04-12	2024-02-21	Incyte Corporation	Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
CA3220274A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
AR126101A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL93136A (en) *	1989-02-23	1995-01-24	Janssen Pharmaceutica Nv	Tetrahydroimidazo (1,4) benzodiazepin-2-thione derivatives, their preparation and pharmaceutical compositions containing them
KR100447539B1 (ko) *	1995-08-02	2004-11-10	뉴캐슬 유니버시티 벤처스 리미티드	벤조이미다졸화합물과이를포함하는제약학적조성물및이화합물을이용한치료방법
ECSP003637A (es) *	1999-08-31	2002-03-25	Agouron Pharma	Inhibidores triciclicos de poli (adp-ribosa) polimerasas

1999
- 1999-09-28 DE DE19946289A patent/DE19946289A1/de not_active Withdrawn
2000
- 2000-09-15 IL IL14841900A patent/IL148419A0/xx unknown
- 2000-09-15 CN CN00813443A patent/CN1376156A/zh active Pending
- 2000-09-15 BR BR0014326-0A patent/BR0014326A/pt not_active IP Right Cessation
- 2000-09-15 HK HK03101161.8A patent/HK1048994A1/zh unknown
- 2000-09-15 JP JP2001526538A patent/JP2003510324A/ja not_active Ceased
- 2000-09-15 DE DE50011656T patent/DE50011656D1/de not_active Expired - Lifetime
- 2000-09-15 EP EP00966022A patent/EP1222191B1/de not_active Expired - Lifetime
- 2000-09-15 PL PL00354118A patent/PL354118A1/xx not_active Application Discontinuation
- 2000-09-15 ES ES00966022T patent/ES2251405T3/es not_active Expired - Lifetime
- 2000-09-15 WO PCT/EP2000/009023 patent/WO2001023386A2/de not_active Ceased
- 2000-09-15 AT AT00966022T patent/ATE310003T1/de not_active IP Right Cessation
- 2000-09-15 CA CA002384265A patent/CA2384265A1/en not_active Abandoned
- 2000-09-15 HU HU0203225A patent/HUP0203225A3/hu unknown
- 2000-09-15 AU AU76567/00A patent/AU7656700A/en not_active Abandoned
- 2000-09-15 SK SK380-2002A patent/SK3802002A3/sk unknown
- 2000-09-15 TR TR2002/00820T patent/TR200200820T2/xx unknown
- 2000-09-15 KR KR1020027003975A patent/KR20020031602A/ko not_active Ceased
- 2000-09-20 AR ARP000104924A patent/AR025721A1/es unknown
2001
- 2001-05-23 ZA ZA200104196A patent/ZA200104196B/xx unknown
2002
- 2002-02-22 ZA ZA200201494A patent/ZA200201494B/xx unknown
- 2002-02-26 BG BG06444A patent/BG106444A/xx unknown
- 2002-03-20 NO NO20021379A patent/NO20021379L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0203225A2 (hu)	2003-01-28
TR200200820T2 (tr)	2002-09-23
ZA200104196B (en)	2002-07-25
WO2001023386A2 (de)	2001-04-05
CN1376156A (zh)	2002-10-23
CA2384265A1 (en)	2001-04-05
ZA200201494B (en)	2003-12-31
KR20020031602A (ko)	2002-05-02
SK3802002A3 (en)	2003-03-04
BR0014326A (pt)	2002-05-28
EP1222191A2 (de)	2002-07-17
DE19946289A1 (de)	2001-03-29
NO20021379D0 (no)	2002-03-20
HK1048994A1 (zh)	2003-04-25
EP1222191B1 (de)	2005-11-16
JP2003510324A (ja)	2003-03-18
PL354118A1 (en)	2003-12-29
AU7656700A (en)	2001-04-30
ATE310003T1 (de)	2005-12-15
ES2251405T3 (es)	2006-05-01
IL148419A0 (en)	2002-09-12
WO2001023386A3 (de)	2002-05-10
HUP0203225A3 (en)	2003-05-28
BG106444A (en)	2002-09-30
DE50011656D1 (de)	2005-12-22
AR025721A1 (es)	2002-12-11

Legal Events

Date	Code	Title	Description
2003-06-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20021379L (no)	2002-03-20	Benzodiazepin-derivater, fremstilling og anvendelse derav
BG105650A (en)	2002-02-28	Azepinoindole derivatives, the production and use thereof
NO20054905L (no)	2006-01-25	2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
CA2349227A1 (en)	2000-05-11	Substituted 2-phenylbenzimidazoles, the production thereof and their use
PT1140944E (pt)	2004-01-30	Derivados de epotilona e sua utilizacao como agentes antitumorais
ATE288431T1 (de)	2005-02-15	Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
BG106585A (en)	2003-03-31	Kinase inhibitors as therapeutic agents
TR200201505T2 (tr)	2003-01-21	Terapötik maddeler olarak pirazolopirimidinler
GEP20094736B (en)	2009-07-27	Prodrugs of piperazine and substituted piperidine antiviral agents
BG108268A (en)	2005-04-30	Pyrazolopyrimidines as therapeutic agents
NO20073465L (no)	2002-12-12	Benzotiazol-derivater
MY140693A (en)	2010-01-15	[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
ES2249309T3 (es)	2006-04-01	Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa.
DE60031886D1 (de)	2006-12-28	Purinderivate
NO20062256L (no)	2006-06-06	Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
MXPA04006266A (es)	2004-09-27	Pirimidotriazinas como inhibidores de fosfatasa.
MXPA05012953A (es)	2006-02-13	Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos.
DK1313740T3 (da)	2006-04-03	Prodrugs af imidazopyridinderivater
AP2000001761A0 (en)	2000-03-31	Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
DK1463731T3 (da)	2006-02-13	Dibenzodiazepinderivater, deres fremstilling og anvendelse
MXPA05004273A (es)	2005-10-18	Derivados de fenilalquil y piridilalquil piperazina.
AP2001002188A0 (en)	2001-06-30	5HT1 antagonists for antidepressant therapy.
DE50201565D1 (de)	2004-12-23	2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
DE60133385D1 (de)	2008-05-08	(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen
NO20054721L (no)	2005-10-13	Substituerte anilinderivater